**REVIEWER A — Domain Expert**

| Criterion | Score (1–5) | Justification |
|-----------|-------------|---------------|
| Impact | 4 | De‑risking for Experiment A is concrete and quantified; open‑source potential is real but depends on adoption. |
| Approach | 5 | Systematic, phased validation with clear success criteria; risk mitigations (fallback, watchdog, containerization) are thorough. |
| Innovation | 4 | AI‑agent + automated microscopy is not entirely new, but the fallback‑controller architecture and safety framework are well‑executed. |
| Preliminary Data | 5 | Extensive, multi‑modal evidence (static, dynamic, watchdog, blind evaluation) – far exceeds typical concept‑stage expectations. |
| PI & Team | 4 | PI has relevant prior integrations; team is lean but functional with remote consultants and documented SOPs. |
| Feasibility | 4 | Low budget and focused scope make success plausible; single 7‑day run is a minor risk. |
| Experimental Design | 3 | Single run without replicates limits failure‑mode generalizability; duration is reasonable but statistical power is weak. |
| Budget | 5 | Extremely lean, every line item justified; contingency reduced appropriately. |
| Clarity | 5 | Well‑structured, thorough, and self‑contained; tables and cross‑references aid readability. |
| Ethics | 5 | Plant cells only; Class 4 laser safety with third‑party audit; watchdog enforcement. |
| Overall | 4 | Solid engineering proposal with mature preliminary work; minor design weaknesses acceptable at this scale. |

**Score Sum: 48/55**

---

**REVIEWER B — Fluff/Impact Auditor**

| Criterion | Score (1–5) | Justification |
|-----------|-------------|---------------|
| Impact | 3 | Risk‑reduction claim (15–25%) is a plausible guess, not backed by formal analysis; broad community impact overstated for a Zeiss‑specific setup. |
| Approach | 4 | Logical flow from completed milestones to final validation; API‑independence plan is necessary but still untested. |
| Innovation | 2 | Using an LLM for tool calling in microscopy is incremental; fallback controller is textbook engineering. |
| Preliminary Data | 4 | Extensive and well‑documented, but all self‑generated; no independent replication. |
| PI & Team | 3 | Thin team with one intern; PI’s AI training is a Coursera course – credible but not deep. |
| Feasibility | 4 | Low cost and focused scope make failure unlikely; single run is a minor concern. |
| Experimental Design | 3 | No biological replicates, no multiple runs – acceptable for engineering but limits generalizability. |
| Budget | 4 | Lean, but $2,400 for “continuous monitoring staffing” could be absorbed by existing PI effort. |
| Clarity | 5 | Excellent structure, clear delineation of completed vs. requested work. |
| Ethics | 5 | Compliant and well‑documented. |
| Overall | 3 | Acceptable proposal, but impact claims are not fully substantiated; innovation is modest. |

**Score Sum: 40/55**

---

**REVIEWER C — Red Team**

| Criterion | Score (1–5) | Justification |
|-----------|-------------|---------------|
| Impact | 2 | De‑risking estimate is unvalidated (no prior benchmark); “open‑source blueprint” requires specialist hardware (Zeiss IM 35). |
| Approach | 3 | Logical, but the single 7‑day run is insufficient to prove long‑term reliability; “1 h/day scheduled maintenance” inflates uptime. |
| Innovation | 2 | LLM + microscopy is not novel; fallback controller is standard. |
| Preliminary Data | 3 | Strong but tailored – watchdog tested only on synthetic unsafe commands, not real‑world scenarios. |
| PI & Team | 2 | Overstretched: PI + intern + remote consultants; no backup if PI is unavailable. |
| Feasibility | 3 | Single failure during 7‑day run (e.g., camera cable) could derail timeline; contingency budget is low. |
| Experimental Design | 2 | No replicates, no multiple runs; confidence interval for κ already includes 0.80; second evaluation may not tighten it. |
| Budget | 4 | Reasonable, but “continuous monitoring staffing” is vague; $480 for archiving is high for a small dataset. |
| Clarity | 4 | Well‑organized, but some sections (Section 8.2) mix success criteria with aspirational targets. |
| Ethics | 5 | Strong safety framework. |
| Overall | 2 | Too risky for the claimed impact; insufficient experimental design to justify the “final validation” label. |

**Score Sum: 32/55**

---

### Combined Verdict

**Combined Score: MIN = 32/55**

**Recommendation: Major Revisions**

**Top 3 Actions:**
1. **Strengthen experimental design** – replace the single 7‑day run with at least three independent 48‑hour runs to provide failure‑mode replication and tighter statistics.
2. **Ground the risk‑reduction claim** – provide a formal sensitivity analysis or cite published benchmarks (e.g., cost‑overrun data from similar instrument integrations) to support the 15–25% figure.
3. **Address team thinness** – either add a named co‑PI or formalize a backup operator (e.g., a trained graduate student) and document the pager‑duty rota explicitly.